scispace - formally typeset
M

Michael Karin

Researcher at University of California, San Diego

Publications -  753
Citations -  246120

Michael Karin is an academic researcher from University of California, San Diego. The author has contributed to research in topics: IκB kinase & Signal transduction. The author has an hindex of 236, co-authored 704 publications receiving 226485 citations. Previous affiliations of Michael Karin include Sanford-Burnham Institute for Medical Research & University of California, Los Angeles.

Papers
More filters
Journal ArticleDOI

Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B.

TL;DR: Using a variety of protease inhibitors, some of which have specificity towards the multicatalytic proteinase complex, it is demonstrated that degradation of I kappa B alpha is required for NF-kappa B activation.
Journal ArticleDOI

IKKα controls formation of the epidermis independently of NF-κB

TL;DR: It is shown that the unique function of IKKα in control of keratinocyte differentiation is not exerted through its IκB kinase activity or through NF-κB, but instead, IKK α controls production of a soluble factor that induces keratinocytes differentiation.
Journal ArticleDOI

Inhibition of NF-κB Activation by Arsenite through Reaction with a Critical Cysteine in the Activation Loop of IκB Kinase

TL;DR: Overexpression of IKKβ (C179A) protects NF-κB from inhibition by arsenite, indicating that despite the involvement of a large number of distinct gene products in this activation pathway, the critical target for inhibition by arsenic is on the IKK catalytic subunits.
Journal ArticleDOI

Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?

TL;DR: The importance of autocrine interleukin 6 (IL-6) in lung and breast cancers and implicate IL-6 as an important activator of oncogenic STAT3 in lung adenocarcinomas and of Jagged-1/Notch signaling in breast tumor mammospheres are outlined.